View in EDS HTML Full Text PDF Full Text

The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.

Saved in:
Bibliographic Details
Title: The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.
Authors: Malempati S; Department of Pediatrics, Oregon Health & Science University, Portland, Oregon., Weigel BJ; Division of Pediatric Hematology/Oncology and Blood and Marrow Transplant, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota., Chi YY; Department of Biostatistics, University of Florida, Gainesville, Florida., Tian J; Department of Biostatistics, University of Florida, Gainesville, Florida., Anderson JR; Merck and Co, North Wales, Pennsylvania., Parham DM; Department of Pediatrics, Children's Hospital of Los Angeles and University of Southern California Keck School of Medicine, Los Angeles, California., Teot LA; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Rodeberg DA; Department of Surgery, East Carolina University, Greenville, North Carolina., Yock TI; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts., Shulkin BL; Department of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee., Spunt SL; Stanford University School of Medicine, Stanford, California., Meyer WH; Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Hawkins DS; Pediatric Hematology/Oncology, Seattle Children's Hospital, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Source: Cancer [Cancer] 2019 Jan 15; Vol. 125 (2), pp. 290-297. Date of Electronic Publication: 2018 Oct 23.
Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30351457
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Malempati+S%22">Malempati S</searchLink>; Department of Pediatrics, Oregon Health & Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Weigel+BJ%22">Weigel BJ</searchLink>; Division of Pediatric Hematology/Oncology and Blood and Marrow Transplant, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.<br /><searchLink fieldCode="AU" term="%22Chi+YY%22">Chi YY</searchLink>; Department of Biostatistics, University of Florida, Gainesville, Florida.<br /><searchLink fieldCode="AU" term="%22Tian+J%22">Tian J</searchLink>; Department of Biostatistics, University of Florida, Gainesville, Florida.<br /><searchLink fieldCode="AU" term="%22Anderson+JR%22">Anderson JR</searchLink>; Merck and Co, North Wales, Pennsylvania.<br /><searchLink fieldCode="AU" term="%22Parham+DM%22">Parham DM</searchLink>; Department of Pediatrics, Children's Hospital of Los Angeles and University of Southern California Keck School of Medicine, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Teot+LA%22">Teot LA</searchLink>; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Rodeberg+DA%22">Rodeberg DA</searchLink>; Department of Surgery, East Carolina University, Greenville, North Carolina.<br /><searchLink fieldCode="AU" term="%22Yock+TI%22">Yock TI</searchLink>; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Shulkin+BL%22">Shulkin BL</searchLink>; Department of Radiological Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.<br /><searchLink fieldCode="AU" term="%22Spunt+SL%22">Spunt SL</searchLink>; Stanford University School of Medicine, Stanford, California.<br /><searchLink fieldCode="AU" term="%22Meyer+WH%22">Meyer WH</searchLink>; Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.<br /><searchLink fieldCode="AU" term="%22Hawkins+DS%22">Hawkins DS</searchLink>; Pediatric Hematology/Oncology, Seattle Children's Hospital, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220374236%22">Cancer</searchLink> [Cancer] 2019 Jan 15; Vol. 125 (2), pp. 290-297. <i>Date of Electronic Publication: </i>2018 Oct 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0374236 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0142 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220008543X%22">0008543X </searchLink><i>NLM ISO Abbreviation: </i>Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30351457
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/cncr.31770
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 290
    Titles:
      – TitleFull: The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Malempati S
      – PersonEntity:
          Name:
            NameFull: Weigel BJ
      – PersonEntity:
          Name:
            NameFull: Chi YY
      – PersonEntity:
          Name:
            NameFull: Tian J
      – PersonEntity:
          Name:
            NameFull: Anderson JR
      – PersonEntity:
          Name:
            NameFull: Parham DM
      – PersonEntity:
          Name:
            NameFull: Teot LA
      – PersonEntity:
          Name:
            NameFull: Rodeberg DA
      – PersonEntity:
          Name:
            NameFull: Yock TI
      – PersonEntity:
          Name:
            NameFull: Shulkin BL
      – PersonEntity:
          Name:
            NameFull: Spunt SL
      – PersonEntity:
          Name:
            NameFull: Meyer WH
      – PersonEntity:
          Name:
            NameFull: Hawkins DS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 01
              Text: 2019 Jan 15
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1097-0142
          Numbering:
            – Type: volume
              Value: 125
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Cancer
              Type: main
ResultId 1